Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP3652 in Female Patients With Bladder Pain Syndrome / Interstitial Cystitis
NCT01613586Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- May 2012
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 2 trial of asp3652 in bladder pain syndrome (BPS), interstitial cystitis (IC), sponsored by Astellas Pharma. Started May 2012; status: completed.
02
Drugs
asp3652
03
Conditions
bladder pain syndrome (BPS)interstitial cystitis (IC)
Beyond the preview
Go deeper on NCT01613586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01613586.